Devyser develops, produces, and commercializes genetic test kits for laboratories in more than 45 countries. The products are used for advanced DNA testing within hereditary diseases, oncology, and transplantation to guide targeted cancer therapies, diagnose a wide array of genetic diseases, and to assist in post-transplant follow-up. Devyser’s products simplify complex genetic testing processes, minimize hands-on time and deliver rapid, accurate, and trusted results. Devyser was founded in 2004 and is based in Stockholm, Sweden.
Diaverum is a Swedish-born, multinational healthcare organisation that provides life-enhancing renal care to patients with Chronic Kidney Disease (CKD), empowering them to live fulfilling lives. Our vision is to transform the industry through patient-centric digital innovations, delivering and broadening access to the highest quality of care. As a global leader and the largest independent renal service provider in Europe, in 2022 we care for around 38,000 patients across 440 clinics in 23 countries globally. Diaverum employs around 13,000 people worldwide and is headquartered in Malmö, Sweden.
Doctrin is digital healthtech company with a clear purpose – to radically improve healthcare! We strive to improve medical quality and the patient experience while making sure healthcare resources are used more efficiently. We can achieve this by helping providers to digitize the patient journey with the right digital tools, processes and training.